Current NDC auxiliary source row compounder:422

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71285-0112
Product Ndc: 71285-0112
Product Ndc Digits: 712850112
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Maintenance 4 to1 Low K (40 mEq) In Plasmalyte A, ph 7.4 with Tromethamine
Proprietary Name Suffix: [empty]
Nonproprietary Name: Maintenance 4 to1 Low K (40 mEq) In Plasmalyte A, ph 7.4 with Tromethamine
Dosage Form Name: SOLUTION
Route Name: INTRACORONARY
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Central Admixture Pharmacy Services, Inc.
Establishment Name: Central Admixture Pharmacy Services, Inc.
Establishment Fei: [empty]
Substance Name: TROMETHAMINE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM GLUCONATE; MAGNESIUM CHLORIDE; SODIUM ACETATE; POTASSIUM CHLORIDE; MANNITOL; MAGNESIUM SULFATE HEPTAHYDRATE
Active Ingredients Info: 4.536 g/1000 mL; 12.53 g/1000 mL; 4.1028 g/1000 mL; 3.9156 g/1000 mL; .234 g/1000 mL; 2.8704 g/1000 mL; 3.2686 g/1000 mL; 7 g/1000 mL; 40.6 meq/1000 mL
History Active Ingredients Raw: TROMETHAMINE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM GLUCONATE; MAGNESIUM CHLORIDE; SODIUM ACETATE; POTASSIUM CHLORIDE; MANNITOL; MAGNESIUM SULFATE HEPTAHYDRATE
History Active Ingredients Info Raw: 4.536 g/1000 mL; 12.53 g/1000 mL; 4.1028 g/1000 mL; 3.9156 g/1000 mL; .234 g/1000 mL; 2.8704 g/1000 mL; 3.2686 g/1000 mL; 7 g/1000 mL; 40.6 meq/1000 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 71285-0112-1
Package Ndc: 71285-0112-1
Package Ndc Digits: 7128501121
Package Ndc11: 71285011201
Package Description: 1000 mL in 1 BAG (71285-0112-1)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:422
Source Row Number: 422
Source Row Hash: abe16cd2a96487ef29712d24142a209396d02e788c514726a1f795b73b1ce508
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACORONARY",
    "PRODUCTNDC": "71285-0112",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "TROMETHAMINE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM GLUCONATE; MAGNESIUM CHLORIDE; SODIUM ACETATE; POTASSIUM CHLORIDE; MANNITOL; MAGNESIUM SULFATE HEPTAHYDRATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "71285-0112-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Maintenance 4 to1 Low K (40 mEq) In Plasmalyte A, ph 7.4 with Tromethamine",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Maintenance 4 to1 Low K (40 mEq) In Plasmalyte A, ph 7.4 with Tromethamine",
    "PACKAGEDESCRIPTION": "1000 mL in 1 BAG (71285-0112-1) ",
    "ACTIVEINGREDIENTSINFO": "4.536 g/1000 mL; 12.53 g/1000 mL; 4.1028 g/1000 mL; 3.9156 g/1000 mL; .234 g/1000 mL; 2.8704 g/1000 mL; 3.2686 g/1000 mL; 7 g/1000 mL; 40.6 meq/1000 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:422
Source Row Number: 422
Status Scope: package
Lookup Ndc: 71285-0112-1
Lookup Ndc Digits: 7128501121
Product Ndc: 71285-0112
Product Ndc Digits: 712850112
Package Ndc: 71285-0112-1
Package Ndc Digits: 7128501121
Package Ndc11: 71285011201
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: abe16cd2a96487ef29712d24142a209396d02e788c514726a1f795b73b1ce508
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51